KSNM/KSID/KOSHIC Guidance for Nuclear Medicine Department Against the Coronavirus Disease 2019 (COVID-19) Pandemic
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bang, Ji-In | - |
dc.contributor.author | Lee, Ho-Young | - |
dc.contributor.author | Cho, Young Seok | - |
dc.contributor.author | Choi, Hongyoon | - |
dc.contributor.author | Chong, Ari | - |
dc.contributor.author | Eo, Jae Sun | - |
dc.contributor.author | Kim, Ji Young | - |
dc.contributor.author | Kim, Tae Sung | - |
dc.contributor.author | Kwon, Hyun-Woo | - |
dc.contributor.author | Lee, Eun Jeong | - |
dc.contributor.author | Lee, Eun Seong | - |
dc.contributor.author | Park, Hye Lim | - |
dc.contributor.author | Park, Soo Bin | - |
dc.contributor.author | Shim, Hye-kyung | - |
dc.contributor.author | Song, Bong-Il | - |
dc.contributor.author | Yoo, Ik Dong | - |
dc.contributor.author | Lee, Kyung Jae | - |
dc.contributor.author | Lee, Hong Jae | - |
dc.contributor.author | Han, Su Ha | - |
dc.contributor.author | Lee, Jin Seo | - |
dc.contributor.author | Park, Jung Mi | - |
dc.contributor.author | Kim, Sung Hoon | - |
dc.date.accessioned | 2021-08-11T08:34:00Z | - |
dc.date.available | 2021-08-11T08:34:00Z | - |
dc.date.issued | 2020-08 | - |
dc.identifier.issn | 1869-3474 | - |
dc.identifier.issn | 1869-3482 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2584 | - |
dc.description.abstract | The dramatic spread of Coronavirus Disease 2019 (COVID-19) has profound impacts on every continent and life. Due to human-to-human transmission of COVID-19, nuclear medicine staffs also cannot escape the risk of infection from workplaces. Every staff in the nuclear medicine department must prepare for and respond to COVID-19 pandemic which tailored to the characteristics of our profession. This article provided the guidance prepared by the Korean Society of Nuclear Medicine (KSNM) in cooperation with the Korean Society of Infectious Disease (KSID) and Korean Society for Healthcare-Associated Infection Control and Prevention (KOSHIC) in managing the COVID-19 pandemic for the nuclear medicine department. We hope that this guidance will support every practice in nuclear medicine during this chaotic period. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한핵의학회 | - |
dc.title | KSNM/KSID/KOSHIC Guidance for Nuclear Medicine Department Against the Coronavirus Disease 2019 (COVID-19) Pandemic | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.1007/s13139-020-00660-9 | - |
dc.identifier.scopusid | 2-s2.0-85089355902 | - |
dc.identifier.wosid | 000559140100001 | - |
dc.identifier.bibliographicCitation | Nuclear Medicine and Molecular Imaging, v.54, no.4, pp 163 - 167 | - |
dc.citation.title | Nuclear Medicine and Molecular Imaging | - |
dc.citation.volume | 54 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 163 | - |
dc.citation.endPage | 167 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002614332 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordAuthor | Coronavirus | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | Nuclear medicine | - |
dc.subject.keywordAuthor | Prevention and control | - |
dc.subject.keywordAuthor | Practice guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.